查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1235973

人絨毛膜促性腺激素全球市場規模調查和預測，按技術/治療領域/最終用戶，區域分析，2022-2029

Global Human Chorionic Gonadotropin Market Size study & Forecast, by Technology, Therapeutic Area, and End User and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球人絨毛膜促性腺激素 (hCG) 市場價值約為 9.2 億美元，在 2022-2029 年的預測期內健康增長率超過 7.6%。預計增長.

在懷孕期間，胎盤會分泌一種稱為人絨毛膜促性腺激素 (hCG) 的激素。 這種激素向身體發出停止月經並增厚子宮內膜以支持發育中的胚胎的信號。 受精後，HCG 水平上升，並在懷孕第 10 週後繼續上升。 在女性生育治療中，hCG 用於維持黃體期，促進卵泡最終成熟，並觸發排卵。 它還用於在雄性激素缺乏和男性性腺機能減退等情況下增加間質細胞產生的睪酮。 老年人男性性腺功能減退症發病率的增加和 hCG 在醫療保健從業者中的日益普及是推動市場增長的主要因素。

多年來，男性性腺功能減退症的流行促進了全球人絨毛膜促性腺激素 (hCG) 市場的增長。 例如，波士頓大學醫學院 (BUMC) 估計，美國約有 4 至 5 百萬男性患有性腺功能減退症。 此外，新興經濟體醫療保健的發展和不同劑量重組 hCG 可用性的增加預計將在預測期內為市場提供有利可圖的增長機會。 然而，對 FDA 發布的 hCG 治療副作用的警告和警告的擔憂阻礙了整個 2022-2029 年預測期內的市場增長。 例如，2020 年 7 月，美國食品藥品監督管理局 (FDA) 發布了一項建議，要求消費者避免使用 HCG 減肥產品。

全球人絨毛膜促性腺激素 (hCG) 市場研究中考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於主要市場參與者的主導地位以及男性和女性與不育相關問題的發生率上升，北美在收入方面佔據了市場主導地位。 另一方面，由於老年人口增加、醫療設施擴張等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

近期市場趨勢

  • 2020 年 7 月，FDA 從可銷售產品中移除了減肥成分 hCG。 FDA 繼續表示，所有宣傳使用 hCG 作為減肥成分的非處方藥和飲食都是虛假的、非法的，並且沒有證據支持他們的說法。 FDA 還表示，產品銷售商建議在使用補充劑時每天攝入 500 卡路裡的熱量，這可能是致命的。

全球人絨毛膜促性腺激素 (hCG) 市場報告範圍

  • 歷史數據：2019-2020-2021
  • 估算基準年：2021 年
  • 預測期：2022-2029
  • 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
  • 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
  • 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區分列的人絨毛膜促性腺激素 (hCG) 市場
    • 人絨毛膜促性腺激素 (hCG) 市場，按技術劃分，2019-2029 年
    • 人絨毛膜促性腺激素 (hCG) 市場，按治療領域劃分，2019-2029 年
    • 人絨毛膜促性腺激素 (hCG) 市場：按最終用戶分類，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章人絨毛膜促性腺激素 (hCG) 全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第 3 章人絨毛膜促性腺激素 (hCG) 的全球市場動態

  • 人絨毛膜促性腺激素 (hCG) 市場影響分析 (2019-2029)
    • 市場驅動力
      • 老年人男性性腺功能減退症的發病率上升
      • hCG 在醫療保健專業人士中越來越受歡迎
    • 市場挑戰
      • 對 FDA 公佈的 hCG 治療副作用的注意事項和警告的擔憂
    • 市場進入潛力
      • 新興經濟體的醫療保健基礎設施增長
      • 不同劑量的重組 hCG 的可用性更高

第 4 章全球人絨毛膜促性腺激素 (hCG) 市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 最佳投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章人絨毛膜促性腺激素 (hCG) 的全球市場：按技術分類

  • 市場概況
  • 人絨毛膜促性腺激素 (hCG) 全球市場：按技術、性能分類 - 潛力分析
  • 人絨毛膜促性腺激素 (hCG) 全球市場按技術估算和預測 2019-2029
  • 人絨毛膜促性腺激素 (hCG) 市場，細分分析
    • 提取天然成分
    • 重組技術

第 7 章。全球人絨毛膜促性腺激素 (hCG) 市場：按治療領域分類

  • 市場概況
  • 全球人絨毛膜促性腺激素 (hCG) 市場：按治療領域劃分的性能潛力分析
  • 2019-2029 年按治療領域分列的人絨毛膜促性腺激素 (hCG) 全球市場估計和預測
  • 人絨毛膜促性腺激素 (hCG) 市場，細分分析
    • 女性不孕症治療
    • 貧血治療
    • 男性性腺功能減退症

第 8 章人絨毛膜促性腺激素 (hCG) 的全球市場：最終用戶

  • 市場概況
  • 全球人絨毛膜促性腺激素 (hCG) 市場：按最終用戶分類，性能潛力分析
  • 2019-2029 年人絨毛膜促性腺激素 (hCG) 全球市場估計和預測（按最終用戶）
  • 人絨毛膜促性腺激素 (hCG) 市場，細分分析
    • 孕婦診所
    • 關於研究機構

第 9 章人絨毛膜促性腺激素 (hCG) 的全球市場：區域分析

  • 人絨毛膜促性腺激素 (hCG) 市場，區域市場概況
  • 北美
    • 美國
      • 按技術估算和預測，2019-2029 年
      • 2019-2029 年各治療領域的估計和預測
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲人絨毛膜促性腺激素 (hCG) 市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區人絨毛膜促性腺激素 (hCG) 市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲人絨毛膜促性腺激素 (hCG) 市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 百時美施貴寶有限公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Ferring Pharmaceuticals Inc
    • Merck & Co., Inc
    • Fresenius Kabi AG
    • Cigna
    • Sun Pharmaceutical Industries Ltd
    • Lee BioSolutions Inc
    • Sanzyme Biologics Private Ltd.
    • Scripps Laboratories Inc.
    • LUPIN Limited

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Human Chorionic Gonadotropin (hCG) Market is valued at approximately USD 0.92 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.6 % over the forecast period 2022-2029. During pregnancy, the placenta secretes a hormone called human chorionic gonadotropin (hCG). It signals the body to cease menstruating and thickens the uterine lining to support a developing embryo. After fertilisation, HCG levels increase and stay elevated for another 10 weeks or more of pregnancy. While treating infertility in women, hCG is used to maintain the luteal phase, promote final follicular maturation, and cause ovulation. It is used to increase testosterone production in males by the Leydig cells in conditions such as hormone insufficiency and male hypogonadism. The increasing incidence of male hypogonadism among the geriatric population and the growing popularity of hCG among healthcare professionals are key factors driving the market growth.

Over the years the prevalence of hypogonadism among male is contributing towards the growth of the Global Human Chorionic Gonadotropin (hCG) Market. For instance - as per Boston University Medical Campus (BUMC) estimates - Hypogonadism affects an estimated 4 to 5 million men in the United States. Also, growing healthcare infrastructure in developing economies as well as the rising availability of recombinant hCGs in different dose strengths would create lucrative growth opportunities for the market over the projected period. However, concern over cautions and warnings issued by the FDA over the probable side effects of hCG therapy hinders the market growth throughout the forecast period of 2022-2029. For instance, in July 2020, The Food and Drug Administration (FDA) announced an advisory for consumers to avoid HCG weight-loss products.

The key regions considered for the Global Human Chorionic Gonadotropin (hCG) Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players as well as the rise in the incidence of infertility-related problems both in males and females. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing expansion of healthcare facilities in the region.

Major market players included in this report are:

  • Bristol Myers Squibb Company
  • Ferring Pharmaceuticals Inc
  • Merck & Co., Inc
  • Fresenius Kabi AG
  • Cigna
  • Sun Pharmaceutical Industries Ltd
  • Lee BioSolutions Inc
  • Sanzyme Biologics Private Ltd.
  • Scripps Laboratories Inc.
  • LUPIN Limited

Recent Developments in the Market:

  • In july 2020, The FDA eliminated hCG, a weight-loss ingredient, from marketable products. The FDA continued by stating that all over-the-counter medications and diets that advertise the use of hCG as a weight-loss ingredient are false and illegal and that there is also no evidence to support the claims made. FDA continued by stating that the restriction of 500 calories per day while using the supplement has been introduced by the product sellers, which could be lethal.

Global Human Chorionic Gonadotropin (hCG) Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Therapeutic Area, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology

  • Natural Source Extraction
  • Recombinant Technology

By Therapeutic Area

  • Female Infertility Treatment
  • Male Hypogonadism
  • Oligospermic Treatment

By End User

  • Fertility Clinics
  • Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Human Chorionic Gonadotropin (hCG) Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Human Chorionic Gonadotropin (hCG) Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.3. Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2019-2029 (USD Billion)
    • 1.2.4. Human Chorionic Gonadotropin (hCG) Market, by End User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Chorionic Gonadotropin (hCG) Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Chorionic Gonadotropin (hCG) Market Dynamics

  • 3.1. Human Chorionic Gonadotropin (hCG) Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of male hypogonadism among the geriatric population
      • 3.1.1.2. Growing popularity of hCG among healthcare professionals
    • 3.1.2. Market Challenges
      • 3.1.2.1. Concern over cautions and warnings issued by the FDA pertaining to the side effects of hCG therapy.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing healthcare infrastructure in developing economies
      • 3.1.3.2. Rising availability of recombinant hCGs in different dose strengths

Chapter 4. Global Human Chorionic Gonadotropin (hCG) Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Human Chorionic Gonadotropin (hCG) Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Human Chorionic Gonadotropin (hCG) Market by Technology, Performance - Potential Analysis
  • 6.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 6.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 6.4.1. Natural Source Extraction
    • 6.4.2. Recombinant Technology

Chapter 7. Global Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area

  • 7.1. Market Snapshot
  • 7.2. Global Human Chorionic Gonadotropin (hCG) Market by Therapeutic Area, Performance - Potential Analysis
  • 7.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • 7.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 7.4.1. Female Infertility Treatment
    • 7.4.2. Oligospermic treatment
    • 7.4.3. Male hypogonadism

Chapter 8. Global Human Chorionic Gonadotropin (hCG) Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Human Chorionic Gonadotropin (hCG) Market by End User, Performance - Potential Analysis
  • 8.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
  • 8.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 8.4.1. Fertility Clinics
    • 8.4.2. Research Institutions

Chapter 9. Global Human Chorionic Gonadotropin (hCG) Market, Regional Analysis

  • 9.1. Human Chorionic Gonadotropin (hCG) Market, Regional Market Snapshot
  • 9.2. North America Human Chorionic Gonadotropin (hCG) Market
    • 9.2.1. U.S. Human Chorionic Gonadotropin (hCG) Market
      • 9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Therapeutic Area breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Human Chorionic Gonadotropin (hCG) Market
  • 9.3. Europe Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.3.1. U.K. Human Chorionic Gonadotropin (hCG) Market
    • 9.3.2. Germany Human Chorionic Gonadotropin (hCG) Market
    • 9.3.3. France Human Chorionic Gonadotropin (hCG) Market
    • 9.3.4. Spain Human Chorionic Gonadotropin (hCG) Market
    • 9.3.5. Italy Human Chorionic Gonadotropin (hCG) Market
    • 9.3.6. Rest of Europe Human Chorionic Gonadotropin (hCG) Market
  • 9.4. Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.4.1. China Human Chorionic Gonadotropin (hCG) Market
    • 9.4.2. India Human Chorionic Gonadotropin (hCG) Market
    • 9.4.3. Japan Human Chorionic Gonadotropin (hCG) Market
    • 9.4.4. Australia Human Chorionic Gonadotropin (hCG) Market
    • 9.4.5. South Korea Human Chorionic Gonadotropin (hCG) Market
    • 9.4.6. Rest of Asia Pacific Human Chorionic Gonadotropin (hCG) Market
  • 9.5. Latin America Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.5.1. Brazil Human Chorionic Gonadotropin (hCG) Market
    • 9.5.2. Mexico Human Chorionic Gonadotropin (hCG) Market
    • 9.5.3. Rest of Latin America Human Chorionic Gonadotropin (hCG) Market
  • 9.6. Rest of The World Human Chorionic Gonadotropin (hCG) Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Bristol Mayer Squibb Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Ferring Pharmaceuticals Inc
    • 10.2.3. Merck & Co., Inc
    • 10.2.4. Fresenius Kabi AG
    • 10.2.5. Cigna
    • 10.2.6. Sun Pharmaceutical Industries Ltd
    • 10.2.7. Lee BioSolutions Inc
    • 10.2.8. Sanzyme Biologics Private Ltd.
    • 10.2.9. Scripps Laboratories Inc.
    • 10.2.10. LUPIN Limited

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Human Chorionic Gonadotropin (hCG) Market, report scope
  • TABLE 2. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • TABLE 5. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by End User 2019-2029 (USD Billion)
  • TABLE 6. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Human Chorionic Gonadotropin (hCG) Market
  • TABLE 71. List of primary sources, used in the study of global Human Chorionic Gonadotropin (hCG) Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Chorionic Gonadotropin (hCG) Market, research methodology
  • FIG 2. Global Human Chorionic Gonadotropin (hCG) Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Human Chorionic Gonadotropin (hCG) Market, key trends 2021
  • FIG 5. Global Human Chorionic Gonadotropin (hCG) Market, growth prospects 2022-2029
  • FIG 6. Global Human Chorionic Gonadotropin (hCG) Market, porters 5 force model
  • FIG 7. Global Human Chorionic Gonadotropin (hCG) Market, pest analysis
  • FIG 8. Global Human Chorionic Gonadotropin (hCG) Market, value chain analysis
  • FIG 9. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Human Chorionic Gonadotropin (hCG) Market, regional snapshot 2019 & 2029
  • FIG 15. North America Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Human Chorionic Gonadotropin (hCG) Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable